Key points are not available for this paper at this time.
Although the use of chloroquine for uncomplicated malaria was successfully discontinued in Zambia, the change of drug policy towards artemether-lumefantrine does not necessarily translate into adequate use of this drug at the point of care.
Zurovac et al. (Thu,) studied this question.